Results 31 to 40 of about 2,548 (196)

Multimodal Imaging Findings Associated With Cardiac Oxalosis Cardiomyopathy

open access: yesJACC: Case Reports
We report the case of a 50-year-old woman with secondary oxalosis following bowel resection resulting in restrictive cardiomyopathy and a diagnosis of cardiac amyloidosis based on the initial workup.
Murtaza Ali, MD   +7 more
doaj   +1 more source

Exosome‐mediated miR‐4660 delivery inhibits OPN promoted hepatoma cells aggression through targeting LGALS3BP

open access: yesJournal of Cell Communication and Signaling, Volume 20, Issue 2, June 2026.
miR‐4660 was found to be downregulated in exosomes derived from SMMC‐OPN cells, a stable HCC cell line that overexpresses OPN. LGALS3BP has been identified as a direct target of miR‐4660, with its expression levels elevated in both SMMC‐OPN cells and their secreted exosomes.
Cuihua Liu   +9 more
wiley   +1 more source

Secondary oxalosis involving the epididymis [PDF]

open access: yes, 2008
Secondary oxalosis in the epididymis is a rare complication among patients who have undergone hemodialysis or peritoneal dialysis. This case report presents secondary oxalosis confirmed via a clinicoradiological-pathologic process-in combination with ...
조남훈, 이광길
core  

Effect of potassium oxalate on liver function and kidney tissue of dogs (beagles) [PDF]

open access: yesArchives of Biological Sciences, 2013
Calcium oxalate crystalluria is a problem of growing concern in dogs. A few reports have discussed acute kidney injury by oxalates in dogs, describing ultrastructural findings in particular.
Mohamaden Walaa   +3 more
doaj   +1 more source

More Than a Question of Correlation: Characterization of the Evidentiary Basis for Biomarker Surrogates Used in European Marketing Authorizations

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1522-1536, June 2026.
Traditionally, clinical outcomes measuring how a patient feels, functions, or survives are preferred endpoints in clinical trials; however, some may take a long time to manifest in slowly developing diseases. Biomarkers, if properly validated, can serve as surrogate endpoints, acting as substitutes for clinical outcomes.
Renske Johanna Grupstra   +4 more
wiley   +1 more source

Cardioembolic stroke in primary oxalosis with cardiac involvement.

open access: yes, 1989
Primary oxalosis is a rare disorder of oxalate metabolism, characterized by nephrocalcinosis, nephrolithiasis, and extrarenal deposition of calcium oxalate in several tissues, including the heart. We report the case of a 34-year-old man with sudden right
M Ribani   +4 more
core   +1 more source

Pulmonary aspergilloma with prominent oxalate deposition

open access: yesClinical Case Reports, 2022
Some Aspergillus species produce oxalic acid, which reacts with tissue calcium or blood to precipitate calcium oxalate. Oxalate crystals can induce lung and kidney damage.
Faten Limaiem   +4 more
doaj   +1 more source

An Unusual Case of Acute Kidney Injury Due to Secondary Oxalate Nephropathy Caused by Herbal Medicine

open access: yesTurkish Journal of Nephrology, 2021
An 81-year-old female patient was examined for acute renal failure. In her renal biopsy, oxalate nephropathy was detected. It was observed that before the deterioration of her renal functions, she had drunk water boiled with leaves of the plane tree ...
Tuba Elif Özler   +6 more
doaj   +1 more source

Paediatric renal transplantation: Paediatric surgeons' perspective

open access: yesSurgical Practice, Volume 30, Issue 2, Page 117-122, May 2026.
Abstract Renal transplantation is the most effective treatment for paediatric end‐stage renal disease (ESRD), offering advantages in survival, growth and neurocognitive development that surpass other renal replacement therapies (RRT). The paediatric setting, however, introduces distinct complexities that distinguish it from adult practice.
Adrian Chi‐heng Fung   +3 more
wiley   +1 more source

Lanthanum carbonate to control plasma and urinary oxalate level in type 1 primary hyperoxaluria?

open access: yesIJU Case Reports, 2021
Introduction The therapy to reduce urinary oxalate excretion in primary hyperoxaluria type 1 is still required. Case presentation A 37‐year‐old hemodialyzed man suffered from systemic oxalosis secondary to primary hyperoxaluria type 1 exhibited a drastic
Agnieszka Pozdzik   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy